Your browser doesn't support javascript.
loading
Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation.
Ahmed, Sairah; Zhao, Qiuhong; Hanel, Walter; Qazilbash, Muzaffar H; Patel, Krina; Narra, Ravi; Kansagra, Ankit; Iqbal, Madiha; Awan, Farrukh T; Christian, Beth; Jaglowski, Samantha M; Kharfan-Dabaja, Mohamed A; Hamadani, Mehdi; Epperla, Narendranath.
Afiliación
  • Ahmed S; Department of Stem Cell Transplantation and Cellular Therapy, M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Zhao Q; Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Hanel W; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Qazilbash MH; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Patel K; Department of Stem Cell Transplantation and Cellular Therapy, M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Narra R; Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Kansagra A; Department of Medicine, BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Iqbal M; Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Awan FT; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida, USA.
  • Christian B; Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Jaglowski SM; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Kharfan-Dabaja MA; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.
  • Hamadani M; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida, USA.
  • Epperla N; Department of Medicine, BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Hematol Oncol ; 40(1): 48-56, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34763367
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Macroglobulinemia de Waldenström / Trasplante de Células Madre Hematopoyéticas / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Macroglobulinemia de Waldenström / Trasplante de Células Madre Hematopoyéticas / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Hematol Oncol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos